Hrt Financial LP Pasithea Therapeutics Corp. Transaction History

Hrt Financial LP

  • $17 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$0.31 - $0.5 $12,751 - $20,566
41,133 New
41,133 $20,000
Q1 2022

May 16, 2022
SELL
$19.4 - $35.8 $246,981 - $455,769
-12,731 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$28.8 - $112.0 $366,652 - $1.43 Million
12,731 New
12,731 $22,000

About Pasithea Therapeutics Corp.

KTTA Quotes by TradingView
  • Ticker KTTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,398,700
  • Market Cap $157M
  • Description
  • Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...
More about KTTA
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email